Reduced Ventricular Proarrhythmic Potential of the Novel Combined Ion-Channel Blocker AZD1305 Versus Dofetilide in Dogs With Remodeled Hearts-Reference-Cited by-同舟云学术

Reduced Ventricular Proarrhythmic Potential of the Novel Combined Ion-Channel Blocker AZD1305 Versus Dofetilide in Dogs With Remodeled Hearts

Published:2012-02 Issue:1 Volume:5 Page:201-209
ISSN:1941-3149
Container-title:Circulation: Arrhythmia and Electrophysiology
language:en
Short-container-title:Circ Arrhythm Electrophysiol

Author:

Johnson Daniel M.¹,de Jong Monique M.J.¹,Crijns Harry J.G.M.¹,Carlsson Leif G.¹,Volders Paul G.A.¹

Affiliation:

1. From the Department of Cardiology (D.M.J., M.M.J.d.J., H.J.G.M.C., P.G.A.V.), Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands; and AstraZeneca Research & Development (L.G.C.), Bioscience, Mölndal, Sweden.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Prevalence of Diagnosed Atrial Fibrillation in Adults

2. The Mechanism of Atrial Antiarrhythmic Action of RSD1235

3. Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

4. Vernakalant

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solubility and lipophilicity of antiarrhythmic drug Dofetilide in modeling physiological media;The Journal of Chemical Thermodynamics;2021-10

2. PDE5 Inhibition Suppresses Ventricular Arrhythmias by Reducing SR Ca 2+ Content;Circulation Research;2021-09-03

3. The canine chronic atrioventricular block model in cardiovascular preclinical drug research;British Journal of Pharmacology;2021-05-04

4. Anti‐arrhythmic investigations in large animal models of atrial fibrillation;British Journal of Pharmacology;2021-04-30

5. How a concentration-effect analysis of data from the eliglustat thorough electrocardiographic study was used to support dosing recommendations;Molecular Genetics and Metabolism;2020-09